BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
Input momentum (manajer yang sebanding):
keluasan pemegang +5.3% ·
aliran saham +6.8% ·
posisi baru bersih +5.0%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 174 | +1 | 1.33B | $76.64B | +6 | −4 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | — |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | — | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | — | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | — |
| Q2 2024 | 19 | — | 159.17M | $6.60B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 43.20M | +2.5% | $2.23B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (pasif) | 34.38M | +5.5% | $1.78B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 23.37M | -0.6% | $1.21B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 20.24M | +32.3% | $1.05B | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Dodge & Cox ✦ | 15.63M | -0.9% | $808.58M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 6 | Millennium Management ✦ | 5.19M | +247.9% | $268.29M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 5.12M | -53.5% | $263.16M | 0.3% | ▼ Trim | 2 | SEC ↗ ×3 |
| 8 | Two Sigma Investments ✦ | 4.72M | -23.5% | $244.28M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 4.49M | +415.6% | $232.53M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 3.90M | +45.7% | $200.47M | 0.3% | ▲ Add | 2 | SEC ↗ ×5 |
| 11 | Point72 Asset Management ✦ | 2.88M | +351.5% | $149.03M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 2.03M | -30.4% | $105.09M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 1.56M | -36.5% | $80.65M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 14 | Renaissance Technologies ✦ | 908.54K | Baru | $47.01M | 0.1% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 868.11K | +239.5% | $44.92M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 610.36K | +10.0% | $31.58M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 337.01K | +17.5% | $17.44M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 226.48K | -0.7% | $11.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Wellington Management ✦ | 150.19K | -9.9% | $7.77M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 20 | GAMCO Investors ✦ | 110.89K | -0.5% | $5.74M | 0.1% | ▼ Trim | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Renaissance Technologies | $47.01M | 0.1% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 6.60K saham, $400 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 6.25K lbr · $403,498
Officer · 500 lbr · $33,750
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi